Influence of chlorpromazine on motility and calcium uptake of boar sperm.

Arch Int Pharmacodyn Ther

Department of Pharmaceutical Sciences, North Dakota State University College of Pharmacy, Fargo 58105.

Published: August 1988

In the motility of sperm, which resembles the automaticity of smooth muscle in some features, calcium plays an important role. Chlorpromazine (CPZ), an inhibitor of calmodulin (CaM), decreases contractile responses of smooth muscle to agonists, alters microsomal calcium movements and inhibits human sperm motility. The involvement of CaM in the contraction of smooth muscle and in sperm motility and its presence in sperm cells have also been established. Therefore, the effects of CPZ on boar sperm motility and microsomal calcium uptake were studied. CPZ (0.05-0.5 mM) was found to depress the motility index of boar sperm. At 60 min time point, an inhibition of the motility index ranging from 28 to 85% was observed (p less than 0.05). The spermatozoa microsomal calcium uptake (5.2 nmol/mg protein/hr) was Mg++- and ATP-dependent and azide insensitive. Ionophore A23187 (1 microM) and EDTA (10 mM) inhibited the uptake (67-94%). The calcium uptake was inhibited (40-60%) by CPZ (0.25 and 0.5 mM). The CPZ-induced inhibition of the motility index or calcium uptake was overcome by additional CaCl2. The observations suggested that the CPZ-caused changes were calcium-mediated and possibly involved CaM.

Download full-text PDF

Source

Publication Analysis

Top Keywords

calcium uptake
20
sperm motility
16
boar sperm
12
smooth muscle
12
microsomal calcium
12
motility
8
motility calcium
8
inhibition motility
8
calcium
7
sperm
7

Similar Publications

Background: Alzheimer's disease (AD) is a complex neurodegenerative disorder marked by progressive memory loss and cognitive decline. The precise molecular mechanisms underlying AD pathogenesis remain uncertain, underscoring the need for further investigation to identify novel therapeutic targets. We recently demonstrated that mitochondrial calcium (Ca) overload significantly contributes to the development of AD, capable of independently driving AD-like pathology.

View Article and Find Full Text PDF

Mitochondrial calcium uniporter complex: An emerging therapeutic target for cardiovascular diseases (Review).

Int J Mol Med

March 2025

Department of Cardiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421000, P.R. China.

Cardiovascular disease (CVD) is currently a major factor affecting human physical and mental health. In recent years, the relationship between intracellular Ca and CVD has been extensively studied. Ca movement across the mitochondrial inner membrane plays a vital role as an intracellular messenger, regulating energy metabolism and calcium homeostasis.

View Article and Find Full Text PDF

Cirrhotic cardiomyopathy is defined as systolic and diastolic dysfunction in patients with cirrhosis, in the absence of any primary heart disease. These changes are mainly due to the malfunction or abnormalities of cardiomyocytes. Similar to non-cirrhotic heart failure, cardiomyocytes in cirrhotic cardiomyopathy demonstrate a variety of abnormalities: from the cell membrane to the cytosol and nucleus.

View Article and Find Full Text PDF

A 51-year-old female patient with diabetes mellitus and hypertension, exhibiting poor control of blood sugar and blood pressure, was unexpectedly found to have multiple large adrenal nodules, excessive cortisol secretion, and adrenocorticotropic hormone inhibition. Cortisol levels remained unresponsive to both low-dose and high-dose dexamethasone tests, leading to a diagnosis of primary bilateral macronodular adrenal hyperplasia. Concurrently, elevated blood calcium and parathyroid hormone levels, along with 99mTc-methoxyisobutyl isonitrile (99mTc-MIBI) imaging revealing increased 99mTc-MIBI uptake in the right inferior parathyroid gland, suggest the consideration of primary hyperparathyroidism.

View Article and Find Full Text PDF

Development of Nonketotic Hyperglycemia Requiring High-Dose Insulin After Supratherapeutic Amlodipine Ingestion.

AACE Clin Case Rep

September 2024

Department of Medicine, Suburban Hospital, Johns Hopkins Medicine, Bethesda, Maryland.

Background/objective: Calcium channel blockers, when taken in overdose quantities, can cause hyperglycemia requiring so-called hyperinsulinemic-euglycemic therapy. The objective of this report was to describe a patient with calcium channel blocker toxicity resulting from overdose of amlodipine.

Case Report: A 74-year-old man presented with a fall and loss of consciousness.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!